Status | Study |
Recruiting |
Study Name: Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases Condition: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue Pyoderma Gangrenosum Date: 2013-09-17 Interventions: Procedure: Collection of biological samples |
Completed |
Study Name: Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA) Condition: DIRA Date: 2013-02-27 Interventions: Drug: Rilonacept |
Completed |
Study Name: Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever Condition: Familial Mediterranean Fever, Date: 2012-09-27 Interventions: Drug: Kineret Patients randomized to active drug will receive Kineret(Anakinra), 100 mg prefilled syring |
Completed |
Study Name: Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS). Condition: TNF-receptor Associated Periodic Syndromes (TRAPS) Date: 2010-11-16 Interventions: Drug: ACZ885 |
Completed |
Study Name: Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF) Condition: Colchicine Resistant/Intolerant Familial Mediterranean Fever Date: 2010-06-21 Interventions: Drug: Canakinumab |
Completed |
Study Name: Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever Condition: Familial Mediterranean Fever Date: 2010-03-16 Interventions: Drug: Canakinumab |
Completed |
Study Name: Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients Condition: Familial Mediterranean Fever Date: 2010-02-24 Interventions: Drug: colchicine sprinkle capsules 0.3 mg |
Recruiting |
Study Name: Heat Intolerance in the Group of FMF Patients Condition: Familial Mediterranean Fever Heat Intolerance Date: 2010-01-28 |
Completed |
Study Name: Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients Condition: Familial Mediterranean Fever Date: 2008-04-08 |
Completed |
Study Name: Rilonacept for Treatment of Familial Mediterranean Fever (FMF) Condition: Familial Mediterranean Fever Date: 2007-12-19 Interventions: Drug: Rilonacept 2.2 mg/kg/wk |